These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8537095

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.
    Munn DH, Garnick MB, Cheung NK.
    Blood; 1990 May 15; 75(10):2042-8. PubMed ID: 2186820
    [Abstract] [Full Text] [Related]

  • 3. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells.
    Baldwin GC, Chung GY, Kaslander C, Esmail T, Reisfeld RA, Golde DW.
    Br J Haematol; 1993 Apr 15; 83(4):545-53. PubMed ID: 7686031
    [Abstract] [Full Text] [Related]

  • 4. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
    Flieger D, Spengler U, Beier I, Sauerbruch T, Schmidt-Wolf IG.
    Z Gastroenterol; 2000 Aug 15; 38(8):615-22. PubMed ID: 11031784
    [Abstract] [Full Text] [Related]

  • 5. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.
    Munn DH, Cheung NK.
    J Exp Med; 1989 Aug 01; 170(2):511-26. PubMed ID: 2526848
    [Abstract] [Full Text] [Related]

  • 6. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity.
    Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan AC.
    Cell Immunol; 1989 Mar 01; 119(1):182-92. PubMed ID: 2646026
    [Abstract] [Full Text] [Related]

  • 7. Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612.
    Pendurthi TK, Parker R, Schlom J, Primus FJ.
    Int J Cancer; 1990 Dec 15; 46(6):1021-8. PubMed ID: 2123477
    [Abstract] [Full Text] [Related]

  • 8. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF.
    Schmid I, Baldwin GC, Jacobs EL, Isacescu V, Neagos N, Giorgi JV, Glaspy JA.
    Cytometry; 1995 Jun 15; 22(2):103-10. PubMed ID: 7587740
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies.
    Ragnhammar P, Frödin JE, Trotta PP, Mellstedt H.
    Cancer Immunol Immunother; 1994 Oct 15; 39(4):254-62. PubMed ID: 7525059
    [Abstract] [Full Text] [Related]

  • 10. Human recombinant interleukin-6 enhances antibody-dependent cellular cytotoxicity of human tumor cells mediated by human peripheral blood mononuclear cells.
    Tsang KY, Finch MD, Primus FJ, Schlom J.
    Cancer Immunol Immunother; 1991 Oct 15; 34(1):9-16. PubMed ID: 1836975
    [Abstract] [Full Text] [Related]

  • 11. GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma.
    Kushner BH, Cheung NK.
    Blood; 1989 May 15; 73(7):1936-41. PubMed ID: 2653466
    [Abstract] [Full Text] [Related]

  • 12. Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity.
    Liesveld JL, Frediani KE, Winslow JM, Duerst RE, Abboud CN.
    J Cell Biochem; 1991 Apr 15; 45(4):381-90. PubMed ID: 1675219
    [Abstract] [Full Text] [Related]

  • 13. Combinations of the cytokines IL-12, IL-2 and IFN-alpha significantly augment whereas the cytokine IL-4 suppresses the cytokine-induced antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2.
    Flieger D, Spengler U, Beier I, Sauerbruch T, Schmidt-Wolf I.
    Cytokine; 2000 Jun 15; 12(6):756-61. PubMed ID: 10843759
    [Abstract] [Full Text] [Related]

  • 14. Macrophage colony-stimulating factor is required for human monocyte survival and acts as a cofactor for their terminal differentiation to macrophages in vitro.
    Brugger W, Kreutz M, Andreesen R.
    J Leukoc Biol; 1991 May 15; 49(5):483-8. PubMed ID: 2016569
    [Abstract] [Full Text] [Related]

  • 15. Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.
    Metelitsa LS, Gillies SD, Super M, Shimada H, Reynolds CP, Seeger RC.
    Blood; 2002 Jun 01; 99(11):4166-73. PubMed ID: 12010822
    [Abstract] [Full Text] [Related]

  • 16. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
    Fogler WE, Klinger MR, Abraham KG, Gottlinger HG, Riethmuller G, Daddona PE.
    Cancer Res; 1988 Nov 15; 48(22):6303-8. PubMed ID: 2460221
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.
    Saleh MN, Khazaeli MB, Wheeler RH, Bucy RP, Liu T, Everson MP, Munn DH, Schlom J, LoBuglio AF.
    Cancer Res; 1995 Oct 01; 55(19):4339-46. PubMed ID: 7671245
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
    Sakurai T, Yamada M, Simamura S, Motoyoshi K.
    Cell Immunol; 1996 Jul 10; 171(1):87-94. PubMed ID: 8660842
    [Abstract] [Full Text] [Related]

  • 19. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W, Nishioka Y, Ozaki S, Jalili A, Verma VK, Hanibuchi M, Abe S, Minakuchi K, Matsumoto T, Sone S.
    Lung Cancer; 2009 Jan 10; 63(1):23-31. PubMed ID: 18524412
    [Abstract] [Full Text] [Related]

  • 20. Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210.
    Watanabe M, Wallace PK, Keler T, Deo YM, Akewanlop C, Hayes DF.
    Breast Cancer Res Treat; 1999 Feb 10; 53(3):199-207. PubMed ID: 10369066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.